News, Insights, & Events
Member News
Orna Therapeutics Announces First-in-Class, Breakthrough Data Demonstrating Potential of Circular RNA Platform at ASGCT 2022
#e28869
Member News
Cue Biopharma Receives FDA Acceptance of Investigational New Drug (IND) Application for CUE-102 in Wilms’ Tumor 1 (WT1) - expressing cancers
#e28869
Member News
Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy
#e28869
Member News
Editas sees clinical promise with new FDA pediatric disease tag for another blood disorder
#e28869
Member News
Be Bio uses Arch Venture-led $130M financing round to harness 'power of the B cell'
#e28869